HomeEWTX • NASDAQ
add
Edgewise Therapeutics Inc
Previous close
$18.18
Day range
$17.42 - $18.29
Year range
$5.12 - $21.60
Market cap
1.69B USD
Avg Volume
651.49K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 34.75M | 35.20% |
Net income | -28.52M | -24.90% |
Net profit margin | — | — |
Earnings per share | -0.33 | 8.33% |
EBITDA | -34.28M | -34.38% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 532.76M | 62.45% |
Total assets | 553.81M | 59.87% |
Total liabilities | 18.86M | 7.43% |
Total equity | 534.94M | — |
Shares outstanding | 93.40M | — |
Price to book | 3.17 | — |
Return on assets | -19.44% | — |
Return on capital | -20.10% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -28.52M | -24.90% |
Cash from operations | -28.60M | -25.29% |
Cash from investing | -268.31M | -647.10% |
Cash from financing | 241.07M | 1,147,866.67% |
Net change in cash | -55.83M | -312.80% |
Free cash flow | -18.86M | 9.21% |
About
Founded
2017
Headquarters
Website
Employees
92